What Researchers Did
Researchers systematically reviewed studies to assess the efficacy and safety of hyperbaric oxygen therapy (HBOT) for patients with COVID-19.
What They Found
Eight articles from three countries were included, all rated as good or fair quality (5 good, 3 fair). Most patients recovered and showed increased blood oxygen saturation after receiving HBOT sessions, suggesting it is a safe and effective oxygenation method for COVID-19 patients.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could potentially serve as an additional treatment option for Canadian patients with COVID-19 who require improved oxygenation. This therapy might contribute to better recovery outcomes by increasing blood oxygen levels.
Canadian Relevance
This systematic review did not include any studies conducted in Canada, therefore direct Canadian relevance is not established.
Study Limitations
The review was limited by the small number of included studies (eight articles) and the heterogeneity in their designs, encompassing both clinical trials and case reports/series.